1071023-32-9

Basic information

• Product Name: Acetamide, N-[(1E)-2-(2-methoxyphenyl)-1-methylethenyl]-
• CAS NO: 1071023-32-9
• Molecular Formula: C12H15NO2
• Molecular Weight: 205.257
• Mol File: 1071023-32-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Acetamide, N-[(1E)-2-(2-methoxyphenyl)-1-methylethenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, N-[(1E)-2-(2-methoxyphenyl)-1-methylethenyl]-(1071023-32-9)
• EPA Substance Registry System: Acetamide, N-[(1E)-2-(2-methoxyphenyl)-1-methylethenyl]-(1071023-32-9)

Safety Data

• Hazardous Substances Data: 1071023-32-9(Hazardous Substances Data)

Upstream product

• 105340-62-3 3-Methyl-4-(2-methoxy-phenyl)-buten-⁽³⁾-on-⁽²⁾-oxim 
• 43021-97-2 1-(2-methoxyphenyl)propan-2-one oxime 
• 1834-30-6 iron(II) acetate 
• 135-02-4 ortho-anisaldehyde 
• 58645-50-4 2-methoxy-β-methyl-β-nitrostyrene 
• 108-24-7 acetic anhydride 
• 60-35-5 acetamide 
• 5211-62-1 1-(2-methoxyphenyl)propan-2-one 

Relevant articles and documents

Practical syntheses of N-acetyl (E)-β-arylenamides

A facile and practical method for the preparation of (E)-β- arylenamides [(E)-N-(1-arylprop-1-en-2-yl]acetamides] has been developed by reductive acetylation of the corresponding oximes with iron(II) acetate as the reducing reagent. Employment of hexamethylphosphoramide as the solvent was found to be critical for the high E/Z selectivity. The methodology has been applied in efficient syntheses of a key chiral intermediate of tamsulosin by asymmetric hydrogenation. Georg Thieme Verlag Stuttgart . New York.

Enantioselective hydrogenation of (Z)- and (E)-β-arylenamides catalyzed by rhodium complexes of monodentate chiral spiro phosphorous ligands: A new access to chiral β-arylisopropylamines

A highly enantioselective rhodium-catalyzed hydrogenation of both (Z)- and (E)-β-arylenamides was developed by using monodentate chiral spiro phosphite and phosphine ligands, respectively. The hydrogenation reaction provides an efficient access to optically active β-arylisopropylamines, important building blocks for the synthesis of biologically active compounds.